Close



Aug 7, 2023 07:07AM
Aug 7, 2023 07:00AM
Feb 24, 2023 07:01AM
Feb 24, 2023 07:00AM
Feb 24, 2023 07:00AM
Feb 15, 2023 07:00AM
Feb 15, 2023 07:00AM Passage Bio to Present Updated Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposium™ 2023
Dec 14, 2022 07:10AM
Dec 14, 2022 07:00AM
Dec 14, 2022 07:00AM
Aug 11, 2022 07:00AM
Aug 11, 2022 07:00AM
Aug 4, 2022 07:00AM
Aug 4, 2022 07:00AM Passage Bio Reports Second Quarter 2022 Financial Results and Provides Recent Business Highlights
Jun 8, 2022 07:30AM
Jun 8, 2022 07:30AM
Jun 8, 2022 07:30AM
May 18, 2022 07:02AM
May 18, 2022 07:00AM
May 18, 2022 07:00AM
May 16, 2022 07:00AM Passage Bio Reports First Quarter 2022 Financial Results and Provides Recent Business Highlights
May 16, 2022 07:00AM
May 2, 2022 04:01PM
May 2, 2022 04:01PM
Mar 29, 2022 07:02AM
Mar 29, 2022 07:00AM
Mar 29, 2022 07:00AM
Mar 10, 2022 07:00AM Passage Bio Doses First Patient in Global Clinical Trial for Infantile Krabbe Disease, A Rare Fatal Pediatric Condition
Mar 10, 2022 07:00AM
Feb 11, 2022 11:00AM
Feb 11, 2022 11:00AM
Feb 11, 2022 11:00AM
Dec 17, 2021 07:01AM
Dec 17, 2021 07:00AM
Dec 17, 2021 07:00AM Passage Bio Announces Positive Interim Safety and Biomarker Data and Advances Phase 1/2 Trial of PBGM01 in GM1 Gangliosidosis
Jul 1, 2021 09:30AM
May 5, 2021 07:00AM
May 5, 2021 07:00AM
Apr 5, 2021 07:03AM
Apr 5, 2021 07:00AM
Apr 5, 2021 07:00AM
Apr 1, 2021 07:05AM Passage Bio (PASG) Reports First Patient Dosed in Imagine-1 Study of PBGM01 Gene Therapy for Infantile GM1 Gangliosidosis
Apr 1, 2021 07:00AM
Apr 1, 2021 07:00AM
Mar 8, 2021 07:06AM
Mar 8, 2021 07:00AM
Mar 8, 2021 07:00AM
Mar 8, 2021 06:40AM
Mar 3, 2021 07:00AM Passage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
Mar 3, 2021 07:00AM

251,649 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All